NCT00614679View on ClinicalTrials.gov

A Novel Catheter Lock Solution for Treatment of Tunneled Hemodialysis Catheter-Associated Bacteremia

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

December 31, 2008

Study Completion Date

December 31, 2009

Conditions
End-Stage Renal DiseaseHemodialysis Catheter-associated Infection
Interventions
DRUG

catheter lock solution consisting of N-acetylcystein, tigecycline and heparin

N-acetylcystein 80 mg/ml, tigecycline 1 mg/ml, and heparin 2000 units/ml. This will be a 5 ml catheter lock solution

Trial Locations (3)

77030

Ben Taub General Hospital, Houston

Michael E. DeBakey VA Medical Center, Houston

The Methodist Hospital, Houston

All Listed Sponsors
lead

University of California, San Diego

OTHER

NCT00614679 - A Novel Catheter Lock Solution for Treatment of Tunneled Hemodialysis Catheter-Associated Bacteremia | Biotech Hunter | Biotech Hunter